Related Funds
Fund Name | Location |
Alcatel-Lucent | Boulogne-Billancourt, France, Ile-de-France |
Bestar Consultant | Beijing, Beijing, China |
Book.weibo.com | - |
Green D Ventures | Boston, Massachusetts, United States |
Guokai Ronghua | - |
infinitas capital | Basel, Basel-Stadt, Switzerland |
Ironweed Capital | California, Palo Alto, United States |
ITS Group | Boulogne-Billancourt, France, Ile-de-France |
LongLine Capital | Beijing, Beijing, China |
Mango V Foundation | - |
McConnell Venture Partners | Charlotte, North Carolina, United States |
McKenna Ventures | Chicago, Illinois, United States |
Murata Manufacturing | Japan, Kyoto, Kyoto Prefecture |
Oita Venture Capital | Japan, Oita, Oita Prefecture |
PCRS Corp | California, Long Beach, United States |
Refex Capital Fund | Chennai, India, Tamil Nadu |
Twilight Venture Partners | Indiana, Indianapolis, United States |
Venture Capital Action Plan | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Purespring Therapeutics | 09 Oct 2024 | London, England, United Kingdom | |||
Form3 | $63M | 10 Sep 2024 | London, England, United Kingdom | ||
IGEM Therapeutics | $17M | 09 Sep 2024 | London, England, United Kingdom | ||
Myricx Pharma | $123M | 08 Jul 2024 | United Kingdom, England, United Kingdom | ||
Grey Wolf Therapeutics | $50M | 23 May 2024 | Oxford, England, United Kingdom | ||
Curve Therapeutics | $55M | 27 Feb 2024 | Southampton, Hampshire, United Kingdom | ||
Tenpoint Therapeutics | $70M | 12 Jul 2023 | Cornwall, England, United Kingdom | ||
OMass Technologies | $13M | 15 May 2023 | Oxford, England, United Kingdom | ||
CyberSmart | $17M | 23 Feb 2023 | London, England, United Kingdom |
– Quantexa, a London-based AI startup, raised $153m in Series D funding.
– The round was led by Warburg Pincus and joined by existing investors Dawn Capital, AlbionVC, Evolution Equity Partners (a specialist cybersecurity VC), HSBC, ABN AMRO Ventures and British Patient Capital.
– The company was valued between $800m and $900m.
– Quantexa got its start out of a gap in the market that Marria identified when he was working as a director at Ernst & Young tasked with helping its clients with money laundering and other fraudulent activity.
– It has now raised over $240m to date.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Purespring Therapeutics | 09 Oct 2024 | London, England, United Kingdom | |||
Form3 | $63M | 10 Sep 2024 | London, England, United Kingdom | ||
IGEM Therapeutics | $17M | 09 Sep 2024 | London, England, United Kingdom | ||
Myricx Pharma | $123M | 08 Jul 2024 | United Kingdom, England, United Kingdom | ||
Grey Wolf Therapeutics | $50M | 23 May 2024 | Oxford, England, United Kingdom | ||
Curve Therapeutics | $55M | 27 Feb 2024 | Southampton, Hampshire, United Kingdom | ||
Tenpoint Therapeutics | $70M | 12 Jul 2023 | Cornwall, England, United Kingdom | ||
OMass Technologies | $13M | 15 May 2023 | Oxford, England, United Kingdom | ||
CyberSmart | $17M | 23 Feb 2023 | London, England, United Kingdom |